Notably, treatment with TAS and metformin significantly improved the glucose tolerance, blood lipid metabolism, Inflammatory factor levels, and INS sensitivity of the model rats, improved the morphology and structure of the liver tissues, reduced steatosis of liver tissues, increased the content of liver glycogen; improved the mucosal structure of the colon, and reduced the infiltration of inflammatory cells. This evidence concerns the gene INS and steatosis.